https://www.vuzix.com/Blog/businesses-identify-vuzix-smart-glasses-as-a-solution-to-supply-chain-problems
Immutep Announced Monday it was Granted Chinese Patent for Eftilagimod Alpha, a Soluble Lag-3 Protein, in Combination With a Chemotherapy Agent
Immutep Limited(NASDAQ: IMMP) is pleased to announcethe grant of a new patent (numberZL 201610221687)entitled "Use of recombinantLAG-3or the derivatives thereof for eliciting a monocyte immune response" by the Chinese Patent Office.
